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Summary
In pancreatic b cells, the endoplasmic reticulum (ER) is an important site for insulin biosynthesis and the folding of newly
synthesized proinsulin. Here, we show that IRE1a, an ER-resident protein kinase, has a crucial function in insulin biosynthe-
sis. IRE1a phosphorylation is coupled to insulin biosynthesis in response to transient exposure to high glucose; inactivation
of IRE1a signaling by siRNA or inhibition of IRE1a phosphorylation hinders insulin biosynthesis. IRE1 activation by high glu-
cose does not accompany XBP-1 splicing and BiP dissociation but upregulates its target genes such as WFS1. Thus, IRE1
signaling activated by transient exposure to high glucose uses a unique subset of downstream components and has a
beneficial effect on pancreatic b cells. In contrast, chronic exposure of b cells to high glucose causes ER stress and hyper-
activation of IRE1, leading to the suppression of insulin gene expression. IRE1 signaling is therefore a potential target for
therapeutic regulation of insulin biosynthesis.Introduction
Pancreatic b cells are specialized for the production and regu-
lated secretion of insulin to control blood glucose levels. In the
presence of hyperglycemia, pancreatic b cells secrete insulin
from a readily available pool. At the same time, an increase in in-
sulin release activates insulin biosynthesis. The endoplasmic re-
ticulum (ER) plays an important role in the biosynthesis of insulin.
As preproinsulin, a precursor of insulin, is synthesized in the cy-
toplasm with a signal peptide, it is cotranslationally translocated
into the lumen of the ER through interaction between the signal
peptide and the signal recognition particle on the ERmembrane.
The signal peptide of preproinsulin is cleaved in the ER and pro-
insulin is produced. In the lumen of the ER, proinsulin undergoes
meticulous protein folding whereby three disulfide bonds are
formed. Properly folded proinsulin is then delivered to the Golgi
apparatus and packaged into secretory granules. The conver-
sion of proinsulin to insulin takes place in the secretory granules.
Mature insulin is then released by exocytosis (Rhodes, 2004;
Rhodes et al., 2005). The frequent fluctuation of blood glucose
levels in humans requires that b cells control proinsulin folding
in the ER with exquisite sensitivity. Any imbalance between
the physiological load of insulin translation into the ER and the
folding capacity of the ER negatively affects the homeostasis
of b cells and leads to ER stress. (Harding et al., 2000a; Kauf-
man, 2002).
The unfolded protein response (UPR) is an intracellular system
that mitigates ER stress (Harding et al., 2002; Kaufman et al.,
2002; Mori, 2000). It has been demonstrated that Inositol Re-
quiring 1 (IRE1), an ER-resident transmembrane protein kinase,
is an upstream component of the UPR and a central regulator of
UPR-specific downstream gene expression. IRE1 senses the
presence of unfolded and misfolded proteins in the ER, whichCELL METABOLISM 4, 245–254, SEPTEMBER 2006 ª2006 ELSEVIER Icauses dimerization, trans-autophosphorylation and conse-
quent activation of IRE1. Activated IRE1 then splices X-box
binding protein-1 (XBP-1) mRNA, which leads to synthesis of
the active transcription factor XBP-1 and upregulation of UPR
genes. These include ER-associated protein degradation genes
such as ER degradation-enhancing a-mannosidase-like protein
(EDEM) and genes that are important for protein folding such as
protein disulfide isomerase-P5 (Calfon et al., 2002; Lee et al.,
2003; Yoshida et al., 2003). IRE1-XBP-1 signaling is also impor-
tant for expansion of the ER (Shaffer et al., 2004; Sriburi et al.,
2004), which, in turn, is needed for the differentiation of secre-
tory cells (Iwakoshi et al., 2003a, 2003b; Reimold et al., 2001).
If the overload of unfolded proteins in the ER is not resolved
via the UPR, prolonged activation of IRE1 causes activation of
JNK kinases, which can lead to apoptosis (Nishitoh et al.,
2002; Urano et al., 2000).
Mammalian cells have two types of IRE1, a and b. IRE1a is
expressed ubiquitously, having high levels of expression in the
pancreas and placenta (Tirasophon et al., 1998), while IRE1b
is expressed only in epithelial cells of the gastrointestinal tract
(Bertolotti et al., 2001; Wang et al., 1998). IRE1-XBP-1 signaling
is particularly important in cells that are active in protein secre-
tion, such as antibody-secreting plasma cells, hepatocytes, and
exocrine pancreatic cells (Calfon et al., 2002; Iwakoshi et al.,
2003a, 2003b; Lee et al., 2005; Reimold et al., 2001). This sug-
gests that physiological ER stress is necessary for the differen-
tiation of secretory cells. However, a physiological inducer of ER
stress has not been studied extensively. Also, no studies have
reported that physiological activation of IRE1 has a function in
regulated synthesis of secretory proteins. We undertook this
study to test the hypothesis that a high glucose level physiolog-
ically activates IRE1 and a unique subset of downstream com-
ponents of IRE1. Under these conditions, IRE1 activation hasNC. DOI 10.1016/j.cmet.2006.07.007 245
A R T I C L Ea beneficial effect aiding in the enhancement of postprandial
proinsulin biosynthesis in pancreatic b cells. In contrast, chronic
exposure of b cells to high glucose causes ER stress and hyper-
activation of IRE1, leading to insulin gene suppression. There-
fore, IRE1 hyperactivatoin and ER stress elicited by chronic
hyperglycemia have a harmful effect in pancreatic b cells. Our
results show that IRE1 signaling is a potential target for thera-
peutic regulation of insulin biosynthesis.
Results
IRE1a in pancreatic islets is activated by high glucose
The degree to which IRE1 is phosphorylated is a direct measure
of the IRE1 activation level. Accordingly, we measured the IRE1
activation level in endocrine pancreatic cells by generating an
anti-phospho-specific IRE1a antibody. We tested the specificity
of that antibody by immunoblot analysis of wild-type and kinase-
inactive K599A human IRE1a (Tirasophon et al., 1998) ex-
pressed in COS7 cells. The antibody specifically detected
wild-type IRE1a, which is autophosphorylated by overexpres-
sion (Tirasophon et al., 2000, 1998), but did not recognize the
kinase-inactive mutant (Figure 1A, upper panel). The expression
of wild-type and kinase inactive K599A IRE1awas confirmed by
an antibody that can recognize both phosphorylated and un-
phosphorylated IRE1a (Urano et al., 2000) (Figure 1A, lower
panel). The expression level of kinase-inactive IRE1a was
much higher than that of wild-type IRE1a as previously reported
(Tirasophon et al., 1998; Urano et al., 2000).
Using anti-phospho-specific IRE1a antibody, we measured
IRE1a activation levels in mouse pancreatic islets, which have
a primary function in the metabolism of glucose by secreting in-
sulin and glucagon. Therefore, we studied the effect of glucose
on IRE1a activation by treating islets with two different concen-
trations of glucose, 2.5 mM and 16.7 mM. Treating islets with
a high concentration of glucose (16.7 mM) for 1 hr increased
the phosphorylation level of IRE1a compared to 2.5 mM (Fig-
ure 1B, left panel), suggesting that IRE1a is activated in pancre-
atic islets in the presence of hyperglycemia. Because physiolog-
ical concentrations of glucose usually fluctuate between 4 mM
and 10mM,we also treated islets with 5mMand 10mMglucose
for 1 hr and measured IRE1a phosphorylation. Treatment with
10mMglucose also increased IRE1 phosphorylation (Figure 1B,
right panel), indicating that IRE1a is activated by high physiolog-
ical concentrations of glucose. The phosphorylation level of
IRE1a by 5mMglucosewas higher than that by 2.5mMglucose,
indicating that IRE1a activation level is coupled to the glucose
concentration. To further study the relationship between glu-
cose concentrations and IRE1a activation, we monitored
IRE1a activation levels in vivo. We measured the phosphoryla-
tion levels of IRE1a in islets 1 hr after the injection of glucose
into C57BL/6 mice. The glucose injection increased plasma
insulin levels as expected. In addition, we found that the
glucose-stimulated IRE1a phosphorylation and the degree of
phosphorylation correlated with the levels of plasma insulin
(Figure 1C). These results indicate that high glucose treatment
activates IRE1a in the pancreatic islets.
To confirm this increase in IRE1a activation by high glucose
treatment, we measured mRNA expression levels of ER stress
markers inmouse islets treatedwith 2.5mMor 16.7mMglucose
for 1 hr using real-time polymerase chain reaction (PCR). Treat-
ment with 16.7 mM glucose caused an increase in the expres-246sion of BiP, Wfs1, Ero1a, Chop, and total Xbp-1 (Figure 2A),
markers for ER stress. Wfs1 is a target gene of IRE1 signaling
in pancreatic b cells (Fonseca et al., 2005). Therefore, we ex-
pected that Xbp-1 splicing would also be activated in islets
treated with high glucose. Unexpectedly, Xbp-1 splicing was
not activated by high glucose treatment (Figure 2A, lowest
panel, right side). To confirm this observation, we treatedmouse
islets with 2.5 mM and 16.7 mM glucose or tunicamycin, a clas-
sic inducer of ER stress for 1 hr, then measured IRE1a phos-
phorylation by immunoblot. We also measured the expression
levels of total Xbp-1 mRNA and spliced Xbp-1 mRNA by real-
time PCR. Both high glucose and tunicamycin treatments in-
duced IRE1a phosphorylation and upregulation of total Xbp-1
mRNA (Figures 2B and 2C). However, only tunicamycin treat-
ment, and not high glucose treatment, induced Xbp-1 splicing
(Figure 2C). These results suggest that high glucose treatment
causes activation of IRE1, that is not accompanied by Xbp-1
splicing.
We hypothesized that the activation of IRE1a caused by tran-
sient exposure to high glucose has beneficial effects on the
function of the pancreatic islets. The majority of cells in pancre-
atic islets are b cells, which produce insulin. Thus, the activation
Figure 1. IRE1a is activated by high glucose in pancreatic islets
A) PIRE1A1 antibody specifically detects the phosphorylated form of IRE1a
protein. Immunoblot analysis of wild-type and kinase-inactive K599A (IRE1aKA)
human IRE1a expressed in COS7 cells using PIRE1A1 antibody (P- IRE1a) or total
IRE1a antibody. PIRE1A1 antibody specifically detects wild-type IRE1a, which is
autophosphorylated by overexpression. The amount of total IRE1a is shown in
the lower panel.
B) Immunoblot analysis of Phospho-Ire1a (P-Ire1a) using lysates frommouse islets
treated with 2.5 mM and 16.7mMglucose (left panel), or 5mM and 10mMglucose
(right panel) for 1 hr.
C)C57BL/6 mice fasted for 14 hr and were then injected intraperitoneally with glu-
cose (2 mg/g) or water. Cellular expression levels of P-Ire1a and actin were deter-
mined by immunoblot analysis using the lysates from the islets of these mice.
Blood glucose levels, measured by glucometer after 30 min of injection were
>350mg/dL inmice injected with glucose and <150mg/dL in control mice. Plasma
insulin levels were measured by ELISA after 1 hr of injection. Shown is a typical
result of an experiment repeated three times.CELL METABOLISM : SEPTEMBER 2006
IRE1 and insulin biosynthesisFigure 2. IRE1 signaling is activated by high-glucose
treatment in pancreatic islets
A)Mouse islets were pretreatedwith 2.5mMglucose
for 1 hr, then treatedwith 2.5mMor 16.7mMglucose
for 1 hr. Expression levels of the ER stress markers
BiP, Wfs1, Ero1a, Chop, total Xbp-1, and spliced
Xbp-1 were measured by real-time PCR (n = 3;
values are mean 6 SEM).
B)Mouse islets were pretreated with 2.5mMglucose
for 1 hr, then treated with 2.5 mM glucose, 16.7 mM
glucose, or tunicamycin (2.5 mg/ml) and 2.5 mM
glucose for 1 hr. Expression levels of phospho-
Ire1a (P-Ire1a), total Ire1a, and actin were measured
by immunoblot.
C)Mouse islets were pretreated with 2.5mMglucose
for 1 hr, then treated with 2.5 mM glucose, 16.7 mM
glucose, or tunicamycin (2.5 mg/ml) and 2.5 mM glu-
cose for 1 hr. Expression levels of total and spliced
Xbp-1 were measured by real-time PCR.of IRE1 induced by high glucose in the islets prompted us to
study the involvement of IRE1 signaling in insulin biosynthesis
in a b cell line. Through the manipulation of glucose concentra-
tion, we found that the IRE1a phosphorylation level is linked to
the insulin secretion level in insulinoma cells, INS-1. Treatment
of INS-1 cells with high glucose (10, 20, and 25 mM) for 3 hr in-
duced both insulin secretion and IRE1a phosphorylation (Fig-
ure 3A), suggesting that IRE1a is a positive regulator of insulin
secretion and biosynthesis. To delineate the pathway by which
IRE1a is activated by a high level of glucose, we studied the
effects of a glucose analog, 2-deoxyglucose (2DG), on IRE1a
activation by glucose. Treating INS-1 cells with 5 mM, 10 mM
glucose, or 5 mM glucose with 10 mM 2DG, then measuring
IRE1a phosphorylation levels, we found that treatment with
2DG decreased IRE1a phosphorylation (Figure 3B), indicating
that glucose metabolism is, in fact, required for IRE1 activation.CELL METABOLISM : SEPTEMBER 2006We also stimulated INS-1 cells with a strong activator for insulin
biosynthesis, using GLP-1 and 5 mM glucose as well as a
combination of GLP-1 and 5 mM glucose with 2DG. Treatment
with GLP-1 and 5 mM glucose increased IRE1a phosphoryla-
tion, whereas treatment with a combination of GLP-1 and 5
mM glucose with 2DG decreased IRE1a phosphorylation
(Figure 3B). Because the activation of insulin biosynthesis by
GLP-1 requires glucose metabolism, this result supports our
finding that glucose metabolism has an important function in
IRE1a phosphorylation.
IRE1a activation by insulin secretagogues differs
from activation by ER stress
To test the extent to which IRE1a is activated by different stimuli,
we treated INS-1 cells with a series of insulin secretagogues, in-
cluding high glucose, arginine, tolbutamide, KCl, and GLP-1.247
A R T I C L EAll of these agents activated IRE1a phosphorylation (Figure 4A).
To compare the difference between IRE1 signaling activated by
insulin secretagogues and that activated by typical ER stress in-
ducers, we treated INS-1 cells with two experimental ER stress
inducers, tunicamycin and thapsigargin, and two insulin secre-
tagogues, high glucose and GLP-1. Then, by immunoblot,
we measured phospho-IRE1a, spliced XBP-1, phospho-JNK,
and PERK expression levels. GLP-1 and high glucose were the
strongest activators of IRE1a (Figure 4B). However, we also ob-
served that tunicamycin was the strongest activator of XBP-1
splicing and thapsigargin was the strongest activator of JNK
phosphorylation (Figure 4B). These results show that insulin se-
cretagogues activate IRE1a, but do not strongly activate known
downstream components of IRE1 signaling such as XBP-1 and
JNK. This finding raised the possibility that IRE1 activation by
high glucose and by tunicamycin and thapsigargin occurs by
different mechanisms. It has been shown previously that IRE1
activation is controlled by an ER-resident molecular chaperone,
BiP (Bertolotti et al., 2000). Under normal, unstressed condi-
Figure 3. IRE1a is activated by high glucose in insulinoma cells
A) INS-1 cells were pretreated with 5 mM glucose for 18 hr, and then with 2.5 mM
glucose for 1 hr. The cells were stimulated with KRB buffer containing 0, 2.5, 10,
20, and 25 mM glucose for 3 hr. Cellular expression levels of phospho-Ire1a (P-
Ire1a), total Ire1a, and actin were measured by immunobot. The insulin secretion
level was measured by ELISA and adjusted by the total amount of protein in cells.
Shown is a typical result of an experiment repeated three times.
B) INS-1 cells were pretreatedwith 5mMglucose overnight, then stimulated with 5
mM glucose, 10 mM glucose, 5 mM glucose with 10 mM 2-deoxyglucose (2DG),
GLP-1 (20 nM) and 5 mM glucose, or a combination of GLP-1 and 5 mM glucose
with 10 mM 2DG for 1 hr. Expression levels of phospho-Ire1a (P-Ire1a), total Ire1a,
phospho-eIF2a (P-eIF2a), total eIF2a, and actin were measured by immunoblot.248tions, BiP binds to the luminal domain of IRE1 and prevents
its dimerization and activation. The accumulation of unfolded
proteins in the ER (i.e., ER stress) correlates with the engage-
ment of BiP with unfolded proteins and the subsequent release
from IRE1, leading to IRE1 dimerization and activation. To study
how IRE1a is activated by different stimuli, we treated INS-1
cells with high glucose or tunicamycin, then examined the inter-
action between IRE1a and BiP by immunoprecipitation. As was
reported, we found that BiP dissociated from IRE1a in response
to tunicamycin treatment of INS-1 cells (Figure 4C). However,
BiP remained associated with IRE1a when INS-1 cells were
treated with high glucose (Figure 4C), showing that IRE1a acti-
vation by a high level of glucose differs from its activation by
tunicamycin treatment. Specifically, activation by high glucose
does not require BiP dissociation.
Knockdown of IRE1 signaling decreases
insulin biosynthesis
Because IRE1 signaling is important for protein folding in the ER,
we hypothesized that IRE1 positively regulates insulin secretion
at the biosynthesis level. To study the role of IRE1a in proinsulin
biosynthesis directly, we inhibited the expression of IRE1a in
INS-1 cells, using siRNA specific for IRE1a. This suppression
of IRE1a expression decreased cellular insulin content, but did
not affect the expression level of glucokinase (Gck), another im-
portant b cell protein, suggesting that the effects of siRNA are
unique to insulin (Figure 5A). We also examined the dominant
negative effect of mutant IRE1a, which lacks kinase activity
(Tirasophon et al., 1998; Urano et al., 2000). The expression of
mutant IRE1a, in which the ATP binding domain site at the lysine
residue is replaced with alanine, decreased both the phosphor-
ylation level of endogenous IRE1a and the insulin content in
INS-1 cells (Figure 5B). To determine whether IRE1a controls in-
sulin biosynthesis at the translation and protein-folding level, we
measured proinsulin biosynthesis in INS-1 cells transfected with
siRNA for IRE1a by pulse-chase. IRE1a suppression was con-
firmed by immunoblot with anti-IRE1a antibody (Figure 5C, sec-
ond panel). This suppression of IRE1a dramatically decreased
proinsulin biosynthesis, indicating that IRE1a functions in insulin
biosynthesis at the translation and protein folding level (Fig-
ure 5C, top panel). However, IRE1a suppression did not affect
the expression levels of the ER proteins, Perk and Pdi, or ex-
pression of cytoplasmic protein Gck. To confirm that the sup-
pression of IRE1a by siRNA does not suppress general protein
translation, we measured total protein biosynthesis by pulse-
chase, finding that total protein biosynthesis was not signifi-
cantly affected by IRE1a siRNA (Figure 5C, bottom panel).
These results indicate that IRE1a signaling has a beneficial ef-
fect on pancreatic b cells, enhancing insulin biosynthesis. To de-
termine the effect of IRE1a on glucose-stimulated insulin secre-
tion (GSIS: the ratio between secreted insulin and cellular insulin
content), we measured GSIS in IRE1a-knockdown b cells. We
transfected INS-1 832/13 cells with siRNA for IRE1a and prein-
cubated the cells with 5 mM glucose overnight, then, stimulated
the cells with 5 mM or 10 mM glucose for 1 hr and measured
GSIS by radioimmunoassay (RIA). GSIS was not suppressed
in IRE1a-knockdown b cells as compared to control cells with
5 mM glucose (Figure 5D, upper panel). GSIS was slightly de-
creased in IRE1a-knockdown b cells with 10mMglucose. These
results suggest that IRE1 has an important function in proinsulin
biosynthesis, but not in insulin secretion. Additionally, siRNACELL METABOLISM : SEPTEMBER 2006
IRE1 and insulin biosynthesisFigure 4. The mechanism of IRE1a activation by in-
sulin secretagogues is different from that of activa-
tion by typical ER stress inducers
A) INS-1 cells were pretreated with 5 mM glucose
overnight, then stimulated with glucose (5 mM and
10 mM), arginine (10 mM), tolbutamide (25 mM), KCl
(30 mM), or GLP-1 (20 nM) for 1hr. Expression levels
of phospho-Ire1a (P-Ire1a), total Ire1a, phospho-
eIF2a (P-eIF2a), total eIF2a, and actin were mea-
sured by immunoblot.
B) INS-1 cells were pretreated with 5 mM glucose for
18 hr, then stimulated with high glucose (16.7 mM),
tunicamycin (2.5 mg/ml), thapsigargin (1 mM), or
GLP-1 (20 mM) for 3 hr. Expression levels of phos-
pho-Ire1a (P-Ire1a), total Ire1a, Xbp-1, phospho-
Jnk (P-Jnk), Perk, and actin were measured by
immunoblot.
C) Ire1a associates with BiP in response to high glu-
cose treatment. INS-1 cells were pretreated with
5 mM glucose for 18 hr, then stimulated with 5 mM
glucose, 16.7 mM glucose, or tunicamycin (2.5 mg/ml)
and 5 mM glucose for 3 hr. Ire1awas immunoprecip-
itated (IP) using lysates from the cells. IP products
were immunoblotted (IB) with anti-BiP antibody.knockdown of IRE1a had no effect on insulin gene expression as
measured by real-time PCR (results not shown).
Sustained IRE1 signaling decreases insulin
gene expression
Treatment of b cells with high physiological concentrations of
glucose for 1 hr enhances proinsulin biosynthesis. In contrast,
it is known that, paradoxically, chronic hyperglycemia is harmful
to this adaptive response. To determine whether chronic hyper-
glycemia causes the typical activation of IRE1a and ER stress,
we treated mouse islets for 24 hr with 5 mM, 11 mM, and 16.7
mM glucose, then measured XBP-1 splicing. This exposure of
islets to high concentrations of glucose (11 mM and 16.7 mM)
caused XBP-1 splicing, indicating that chronic hyperglycemia
induces typical IRE1 activation and ER stress (Figure 6A). We
cultured b cells with low (2.5 mM), intermediate (11 mM), and
high (25 mM) concentrations of glucose for 3 and 7 days, then
measured IRE1 activation levels and cellular insulin content to
test whether a high level of sustained IRE1 activation (i.e., ER
stress) has a harmful effect on insulin biosynthesis. Treatment
of the cells with 11 mM glucose increased both the phosphory-
lation level of IRE1a and the cellular insulin content as compared
to the levels in cells treated with 2.5 mM glucose (Figure 6B,
lanes 2 and 5). Treatment with 25 mM glucose further increased
the phosphorylation level of IRE1a, but decreased the cellular in-
sulin content (Figure 6B, lanes 3 and 6), suggesting that hyper-CELL METABOLISM : SEPTEMBER 2006activation of IRE1a may decrease insulin biosynthesis. We also
measured the expression levels of rat insulin mRNA in INS-1
cells treated with different concentrations of glucose for 3
days by real-time PCR. The expression levels of insulin mRNA
dramatically decreased in the cells treated with 25 mM glucose
(Figure 6C), suggesting that sustained activation of IRE1a
(i.e., ER stress) may decrease insulin biosynthesis at the tran-
scription level. However, these observations may reflect that
the IRE1 activation and the UPR cannot keep up with the dam-
age that chronic hyperglycemia causes.
Discussion
It has been shown that upstream components of ER stress sig-
naling, IRE1 and XBP-1, play important roles in development of
antibody-secreting plasma cells, hepatocytes, and exocrine
pancreatic cells (Lee et al., 2005; Reimold et al., 2000, 2001).
Here, we have shown that regulated activation of IRE1a under
physiological settings has an important function in pancreatic
b cells. Postprandial hyperglycemia activates IRE1a, leading to
the enhancement of proinsulin biosynthesis. We have therefore
determined that high glucose is a physiological activator of the
UPR in pancreatic b cells. Since the activation of IRE1 by tran-
sient exposure to high glucose does not accompany XBP-1
splicing or JNK activation, we have named this unique biological
phenomenon ‘‘Stimulus-Coupling Adaptation to ER Folding249
A R T I C L EFigure 5. Inhibition of IRE1 signaling by siRNA
decreases insulin biosynthesis in b cells
A) INS-1 cells were transfected with siRNA specific
for rat Ire1a (final concentration, 20 nM) or siRNA
for GFP as a control. Insulin, total Ire1a, glucokinase
(Gck), and actin expression levels were analyzed by
immunoblot. Shown is a typical result of an experi-
ment repeated three times.
B) INS-1 cells were transfected with the kinase-inac-
tive form of IRE1a (IRE1aK599A) or pcDNA3-EGFP.
After transfection, the cells were pretreated with
2.5 mM glucose for 18 hr, then with 0 mM glucose
for 1 hr. The cells were stimulated with KRB buffer
containing 25 mM glucose for 3 hr. Expression levels
of total Ire1a, phophorylated Ire1a (P-Ire1a), insulin,
and actin expression were measured by immuno-
blot. Shown is a typical result of an experiment re-
peated three times.
C) INS-1 cells were transfected with siRNA specific
for rat Ire1a (final concentration, 20 nM) or siRNA-
scramble (Qiagen) as a control. After transfection,
the cells were pretreated with 11 mM glucose for
18 hr, then stimulated with 16.7 mM glucose and in-
cubated with [35S] methionine for 1 hr. 35S-labeled
proinsulin was immunoprecipitated and subjected
to SDS-PAGE analysis followed by visualization
with a phosphoimager. 35S-labeled total protein
was also analyzed by SDS-PAGE followed by visual-
ization with a phosphoimager. Expression levels of
total Ire1a, Perk, Pdi, Gck, and Actin were measured
by immunoblot.
D) INS-1 832/13 cells were transfected with siRNA
specific for rat Ire1a or scramble siRNA (final con-
centration, 20 nM). After transfection, the cells were
pretreated with 5 mM glucose for 18 hr, then stimu-
lated with 5 mM glucose or 10 mM glucose for 1 hr.
Secreted insulin and cellular insulin content were
measured by RIA: the ratio between secreted and
cellular insulin (glucose-stimulated insulin secretion,
GSIS) was calculated for each sample.(SCAEF)’’. The components of SCAEF probably have important
functions in proinsulin biosynthesis in pancreatic b cells. For ex-
ample, an ER-resident oxidoreductase, ERO1a, is upregulated
by transient high glucose and functions in proinsulin folding (Lip-
son and Urano, unpublished observations). Since ERO1a is an
activator for PDI, which has a crucial role in disulfide bond forma-
tion (Tu and Weissman, 2004), ERO1a may activate insulin bio-
synthesis by enhancing disulfide bond formation of proinsulin
in the ER. Future studies may benefit greatly from the use of
activators and components of SCAEF. These may help reveal
different and perhaps yet unknown UPR pathways that are not
evident through the manipulation of cells with severe ER stress
inducing drugs such as tunicamycin and thapsigargin.
The activation of IRE1a by transient exposure to high glucose
positively regulates proinsulin biosynthesis. It has been shown250that another upstream component of ER stress signaling,
PKR-like ER kinase (PERK) is also important in proinsulin bio-
synthesis (Harding et al., 2001). PERK is highly expressed in
pancreatic islets (Harding et al., 1999; Shi et al., 1998). Activated
PERK phosphorylates the a subunit of eukaryotic translation ini-
tiation factor 2 (eIF2a), leading to the attenuation of general pro-
tein translation. This reduces the ERworkload and protects cells
against apoptosis resulting from ER stress (Harding et al.,
2000b). In islets from PERK knockout mice, insulin biosynthesis
stimulated by high glucose is markedly increased as compared
to that in control mice, indicating that PERK is needed to sup-
press insulin biosynthesis by high glucose in b cells (Harding
et al., 2001). This observation, combined with our present
results, suggests that IRE1a may be a positive regulator and
that PERK may be a negative regulator of insulin biosynthesis.CELL METABOLISM : SEPTEMBER 2006
IRE1 and insulin biosynthesisFigure 6. Sustained activation of IRE1 signaling
decreases insulin gene expression
A)Mouse islets were treated with 5 mM, 11 mM, and
16.7 mM glucose for 24 hr. Spliced XBP-1 mRNA ex-
pression levels were measured by quantitative real-
time PCR. Error bars represent the SD of duplicate
determinations.
B) INS-1 cells were treated with 2.5 mM, 11 mM, and
25 mM glucose for 3 days and 7 days. Expression
levels of total Ire1a, phosphorylated Ire1a, Insulin,
and Actin were measured by immunoblot. Shown is
a typical result of an experiment repeated three
times.
C) INS-1 cells were treated with 2.5 mM, 11 mM, and
25 mM glucose for 7 days. Insulin 1 (Ins1) and insulin
2 (Ins2) mRNA expression levels were measured by
quantitative real-time PCR. Error bars represent the
SD of triplicate determinations.However, it has been reported that deregulated eIF2a phos-
phorylation also leads to declining glucose homeostasis (Scheu-
ner et al., 2001). Therefore, the derepression of proinsulin bio-
synthesis in Perk knockout mice may reflect the defect in
glucose homeostasis. Mutations in the EIF2AK3 gene encoding
PERK have been reported in Wolcott-Rallison syndrome, a rare
form of juvenile diabetes (Delepine et al., 2000). PERK knockout
mice also develop diabetes as a consequence of a high level of
ER stress in the pancreas (Harding et al., 2001). Thus, the bal-
ance between IRE1a and PERK signaling appears to be impor-
tant in the maintenance of b cell homeostasis. Indeed, an imbal-
ance between these two pathways may cause b cell death.
Our results also suggest that IRE1 activation by high glucose
occurs by a different mechanism than activation by tunicamycin,
an extreme ER stress inducer. One current model of IRE1 acti-
vation is a ‘‘Competitive Deprivation’’ model of BiP dissociation
(Bertolotti et al., 2000). According to this model, BiP binds to the
luminal ER domain of IRE1 under normal conditions and pre-
vents dimerization and subsequent activation of IRE1. Under
ER stress conditions, BiP engages with unfolded proteins and
is released from IRE1, leading to IRE1 dimerization and activa-
tion. It is known that BiP dissociates from IRE1 under ER stress
conditions caused by nonphysiological experimental condi-CELL METABOLISM : SEPTEMBER 2006tions. Thus, it is possible that under extreme ER stress BiP
needs to be dissociated from IRE1 to fully activate IRE1 signal-
ing, or to signal that conditions in the ER cannot be resolved via
the UPR. However, the ‘‘competitive deprivation’’ model may
not account for the adaptation to physiological ER stress
caused by frequent fluctuations in protein folding in the ER. Re-
cently, it was shown that the BiP binding domain of IRE1 is not
the principal determinant of IRE1 activation (Kimata et al., 2004).
Also, Walter and his colleagues showed that IRE1 can be di-
rectly activated by unfolded proteins in the ER, and that BiP
binding and release is not a requirement for control of IRE1 ac-
tivity. They suggested that BiP binding to IRE1 may serve to
dampen activation of downstream IRE1 signaling targets (i.e.,
XBP-1 or JNK) under conditions of mild ER stress (Credle
et al., 2005). Our finding of IRE1 activation without BiP dissoci-
ation by high glucose supports this possibility.
Physiological activation of IRE1 (i.e., SCAEF) is unlikely to ac-
tivate apoptosis signaling pathways. This conclusion is sup-
ported by our finding that high-glucose activation of IRE1 does
not activate JNK signaling pathways, which are proapoptotic
components of the UPR. However, we were surprised to find
that XBP-1 also is not spliced by high-glucose activation either,
indicating that IRE1-XBP-1 signaling is not essential for insulin251
A R T I C L Efolding in b cells under certain physiological conditions. These
observations are supported by recent work from the Glimcher
laboratoryshowing thatXBP-1knockoutmicehaveasevereexo-
crine pancreatic phenotype, whereas islets from these same
mice are indistinguishable from wild-type islets (Lee et al.,
2005). It is possible that in endocrine pancreatic tissue, IRE1
has other target mRNAs that are subject to its endonuclease
activity. These mRNAs may compete with XBP-1 mRNA so that
XBP-1 is not spliced under physiological conditions when glu-
cose is high and the b cells need to process large quantities of
proinsulin. The physiological relevance of this mechanism, how-
ever, remains tobedeterminedand requires further investigation.
We have shown that IRE1 has important physiological func-
tions in pancreatic b cells: it is activated by high glucose and
positively regulates proinsulin biosynthesis. Nevertheless, IRE1
activation could have a pathological effect under chronic patho-
logical conditions or in other tissues. The major abnormality in
patients with type 2 diabetes is peripheral resistance to the ac-
tion of insulin, which leads to a prolonged increase in insulin bio-
synthesis in response toelevatedofglucose levels. Thesecretion
capacity of the ER is then overwhelmed, causing prolonged ac-
tivation of the IRE1 signaling pathway. This could lead to glucose
toxicity associatedwith hyperglycemia due to insulin resistance.
Glucose toxicity is defined as nonphysiological and potentially
irreversible b cell damage caused by chronic exposure to supra-
physiological glucose concentrations (Leahy, 2004; Robertson
et al., 2004). Our observation regarding IRE1 hyperactivation
and the suppression of insulin biosynthesis suggests that
chronic ER stress is a cause for glucose toxicity. However, this
observation may reflect that the stress response cannot keep
up with the damage that chronic hyperglycemia causes. More
studies are needed to determine the relationship between IRE1
hyperactivation (i.e, ER stress) and glucose toxicity.
In addition, activation of IRE1-JNK signaling is an important
contributor to insulin resistance in the liver cells of patients
with type 2 diabetes. Obesity causes ER stress in the liver and
leads to hyperactivation of JNK signaling (Ozcan et al., 2004),
which, in turn, causes serine phosphorylation of insulin receptor
substrate-1 (IRS-1) and inhibits insulin action in liver cells.
Therefore, a high level of ER stress in liver cells could contribute
to the development of insulin resistance in patients with type 2
diabetes. It has also been shown that a strong IRE1-JNK activa-
tion by the accumulation of expanded polyglutamine repeats
seen in Huntington disease induces neuronal cell death (Nishi-
toh et al., 2002). These findings indicate that activation of IRE1
by pathological conditions, such as obesity, polyglutamine
accumulation, and chronic hyperglycemia, is harmful to cells.
In contrast, physiological IRE1 activation by transient high
glucose levels in pancreatic b cells has a beneficial effect.
Therefore, a drug or system to induce a physiological level of
IRE1 activation could be used to enhance insulin biosynthesis
and secretion in patients with diabetes, and could lead to the
development of new and more effective clinical approaches to
the treatment of this disorder.
Experimental procedures
Cell culture and transfection of small interfering RNA
Rat insulinoma cells, INS-1 and INS-1 832/13, and mouse islets were cul-
tured in RPMI 1640 supplemented with 10% FBS. The Cell Line Nucleofector
Kit T with the Nucleofector Device (Amaxa Biosystems, Gaithersburg, MD)252was used to transfect small interfering RNA (siRNA) for IRE1a into INS1 cells.
At QIAGEN (Valencia, CA), siRNAs for rat IRE1a were designed and synthe-
sized: for rat IRE1a, AAGGCGATGATCTCAGACTTT.
ELISA
An ELISA assay was performed for mouse and rat insulin using the 1-2-3
UltraSensitive Mouse Insulin ELISA kit (Alpco Diagnostics, Windham, NH).
Glucose-stimulated insulin secretion
INS-1 832/13 cells were transfected with siRNA for IRE1a (final concentra-
tion: 20 nM) and preincubated with 5 mM glucose overnight, then stimulated
with 5mM or 10mM glucose for 1 hr. Wemeasured the insulin secretion level
and cellular insulin content by radioimmunoassay (RIA) (Linco Diagnostics,
St. Charles, MO). The ratio between secreted insulin and cellular insulin con-
tent was calculated.
Immunoblotting and immunoprecipitation
Cells were lysed in ice-cold M-PER buffer (PIERCE, Rockford, IL) containing
protease inhibitors for 15minon ice then the lysateswereclearedbycentrifug-
ing the cells at 13,0003 g for 15min at 4C. Lysates were normalized for total
protein (10 mg per lane), separated using 4%–20% linear gradient SDS-PAGE
(BioRad,Hercules,CA) and electroblotted. Anti-phospho IRE1a antibodywas
generated from bulk antiserum by affinity purification followed by adsorption
against the nonphospho analog column peptide (Open biosystems, Hunts-
ville, AL). The peptide sequence for generating the antibody was CVGRH
(pS) FSRRSG. This phosphopeptide was synthesized, multi-link-conjugated
to KLH, and used to immunize 2SPF rabbits. Rabbit anti-total-IRE1a antibody
(B9134) was generated using a peptide, EGWIAPEMLSEDCK. Anti-actin anti-
body was purchased from Sigma (St. Louis, MO), anti-BiP (GRP78) and anti-
PDI antibodies were purchased from Stressgen (Ann Arbor, MI), anti-eIF2a
antibody was purchased from Sanat Cruz Biotechnology (Santa Cruz, CA),
anti-phospho-eIF2a and anti-phospho-JNK antibodies were purchased
fromCell Signaling (Danvers,MA), andanti-insulin antibodieswerepurchased
from Santa Cruz Biotechnology (Santa Cruz, CA) and Sigma (St. Louis, MO).
For the immunoprecipitation, cellswere lyced in ice-cold buffer (20mMHepes
[pH 7.5], 1% Triton X-100, 150 mMNaCl, 10% glycerol, 1mM EDTA) contain-
ing protease inhibitors for 15 min on ice. IRE1 was immunoprecipitated from
the lysates with anti-total-IRE1a antibody NY200 (Bertolotti et al., 2000).
Insulin biosynthesis
INS-1 cells were pretreated with 5 mM glucose in RPMI for 18 hr, then with
2.5 mM glucose in KRB buffer (135 mM NaCl, 3.6 mM KCl, 10 mM Hepes
[pH 7.4], 5 mM NaHCO3, 0.5 mM NaH3PO4, 0.5 mM MgCl2, 1.5 mmM
CaCl2) for 1 hr. The cells were stimulated with KRB buffer containing 16.7
mM of glucose for 1h. Lysates from those cells were subjected to SDS-
PAGE. The active form of IRE1a (i.e., P-Ire1a) was detected by immunoblot
analysis with anti-phospho specific IRE1a antibody and cellular expression
levels of total IRE1a, insulin, and actin were measured by immunoblot anal-
ysis using the same lysates. We also measured the insulin secretion level and
cellular insulin content by ELISA or RIA.
Proinsulin biosynthesis was analyzed by proinsulin immunoprecipitation of
[35S] methionine-radiolabeled INS-1 lysates as described (Alarcon et al.,
2002; Wicksteed et al., 2003, 2001). Immnoprecipitated 35S-labeled proinsu-
lin was then subjected to SDS-PAGE and visualized by phosphoimager.
Isolating islets from mouse pancreata
Mice were anesthetized by intraperitoneal injection of sodium pentobarbital.
Pancreatic islets are then isolated by pancreatic duct injection of 500 U/ml of
collagenase solution followed by digestion at 37C for 40 min with mild shak-
ing. Islets were washed several times with HBSS, separated from acinar cells
on a discontinuous Ficoll 400 gradient, viewed under a dissecting micro-
scope, and hand-selected.
Real-time polymerase chain reaction
Total RNA was isolated from the cells by the guanidine-thiocyanate-acid-
phenol extraction method and reverse transcribed using 1 mg of total RNA
from cells with Oligo-dT primer. For the thermal cycle reaction, the ABI prism
7000 sequencer detection system (Applied Biosystems, Foster City, CA) was
used at 50C for 2min, 95C for 10min, then 40 cycles at 95C for 15 s, and at
60C for 1 min.CELL METABOLISM : SEPTEMBER 2006
IRE1 and insulin biosynthesisThe relative amount for each transcript was calculated by a standard curve
of cycle thresholds for serial dilutions of cDNA sample and normalized to the
amount rat actin. The polymerase chain reaction (PCR) was performed in trip-
licate for each sample, then all experiments were repeated twice. The follow-
ing sets of primers and Cyber Green (Applied Biosystems) were used for
real-time PCR: for mouse actin, GCAAGTGCTTCTAGGCGGAC and AAGAA
AGGGTGTAAAACGCAGC; for mouse BiP, TTCAGCCAATTATCAGCAAA
CTCT and TTTTCTGATGTATCCTCTTCACCAGT; for mouse WFS1, CCATC
AACATGCTCCCGTTC and GGGTAGGCCTCGCCATACA; for mouse Ero1a,
GCTCTCTCCAAAGTGCTTCCA and TGCATCCTGAACTTTATTCCCA; for
mouse Chop, CCACCACACCTGAAAGCAGAA and AGGTGAAAGGCAGG
GACTCA; for mouse total XBP-1, TGGCCGGGTCTGCTGAGTCCG and
GTCCATGGGAAGATGTTCTGG; formouse spliced XBP-1, CTGAGTCCGAA
TCAGGTGCAG (original CAG sequence was mutated to AAT to reduce the
background signal from unspliced XBP-1) and GTCCATGGGAAGATGTT
CTGG; for rat actin, GCAAATGCTTCTAGGCGGAC and AAGAAAGGGTGT
AAAACGCAGC; for rat insulin 1, GTCCTCTGGGAGCCCAAG and ACAGAG
CCTCCACCAGG; for rat insulin 2, ATCCTCTGGGAGCCCCGC and AGAGA
GCTTCCACCAAG; for rat spliced XBP-1, CTGAGTCCGAATCAGGTGCAG
(original CAG sequence was mutated to AAT to reduce the background
signal from unspliced XBP-1) and ATCCATGGGAAGATGTTCTGG.
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